{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:29:48Z","timestamp":1768886988424,"version":"3.49.0"},"reference-count":56,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2131\/jts.38.445","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T22:57:32Z","timestamp":1368226652000},"page":"445-458","source":"Crossref","is-referenced-by-count":9,"title":["Biochemical evaluation of the neurotoxicity of MPTP and MPP&lt;sup&gt;+&lt;\/sup&gt; in embryonic and newborn mice"],"prefix":"10.2131","volume":"38","author":[{"given":"Takafumi","family":"Sai","sequence":"first","affiliation":[{"name":"Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo"},{"name":"Pathology Group, Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Berry, C., La Vecchia, C. and Nicotera, P. (2010): Paraquat and Parkinson&rsquo;s disease. Cell Death Differ., <b>7<\/b>, 1115-1125.","DOI":"10.1038\/cdd.2009.217"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bourque, M., Dluzen, D.E. and Di Paolo. T. (2009): Neuroprotective actions of sex steroids in Parkinson&rsquo;s disease. Front Neuroendocrinol., <b>30<\/b>, 142-157.","DOI":"10.1016\/j.yfrne.2009.04.014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chen, X., Lan, X., Roche, I., Liu, R. and Geiger, J.D. (2008): Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J. Neurochem., <b>107<\/b>, 1147-1157.","DOI":"10.1111\/j.1471-4159.2008.05697.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chiba, K., Trevor, A.J. and Castagnoli, N.Jr. (1985): Active uptake of MPP<sup>+<\/sup>, a metabolite of MPTP, by brain synaptosomes. Biochem. Biophys. Res. Commun., <b>128<\/b>, 1228-1232.","DOI":"10.1016\/0006-291X(85)91071-X"},{"key":"5","unstructured":"Daniels, A.J. and Reinhard, J.F.Jr. (1998): Energy-driven uptake of the neurotoxin<b> <\/b>1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J. Biol. Chem., <b>263<\/b>, 5034-5036."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Del Zompo, M., Piccardi, M.P., Ruiu, S., Quartu, M., Gessa, G.L. and Vaccari, A. (1993): Selective MPP<sup>+<\/sup> uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity. Br. J. Pharmacol., <b>109<\/b>, 411-414.","DOI":"10.1111\/j.1476-5381.1993.tb13584.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Di Monte, D.A., Wu, E.Y., Irwin, I., Delanney, L.E. and Langston, J.W. (1992): Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes. Glia, <b>5<\/b>, 48-55.","DOI":"10.1002\/glia.440050108"},{"key":"8","unstructured":"Dluzen, D.E., McDermott, J.L. and Liu, B. (1998): Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57\/B1 mice. Neurotoxicol. Teratol., <b>18<\/b>, 603-606."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dluzen, D.E., McDermott, J.L. and Liu, B. (1996): Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J. Neurochem., <b>66<\/b>, 658-666.","DOI":"10.1046\/j.1471-4159.1996.66020658.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Du, F., Li, R., Huang, Y., Li, X. and Le, W. (2005): Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. Eur. J. Neurosci., <b>22<\/b>, 2422-2430.","DOI":"10.1111\/j.1460-9568.2005.04438.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Freyaldenhoven, T.E., Cadet, J.L. and Ali, S.F. (1996): The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent. Brain Res., <b>735<\/b>, 232-238.","DOI":"10.1016\/0006-8993(96)00598-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Ghosh, A., Roy, A., Liu, X., Kordower, J.H., Mufson, E.J., Hartley, D.M., Ghosh, S., Mosley, R.L., Gendelman, H.E. and Pahan, K. (2007): Selective inhibition of NF-&kappa;B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson&rsquo;s disease. Proc. Natl. Acad. Sci. USA, <b>104<\/b>, 18754-18759.","DOI":"10.1073\/pnas.0704908104"},{"key":"13","doi-asserted-by":"crossref","unstructured":"He, X.J., Nakayama, H., Dong, M., Yamauchi, H., Ueno, M., Uetsuka, K. and Doi, K. (2006): Evidence of apoptosis in the subventricular zone and rostral migratory stream in the MPTP mouse model of Parkinson disease. J. Neuropathol. Exp. Neurol., <b>65<\/b>, 873-882.","DOI":"10.1097\/01.jnen.0000235115.29440.ce"},{"key":"14","doi-asserted-by":"crossref","unstructured":"He, X.J., Uetsuka, K. and Nakayama, H. (2008a): Neural progenitor cells are protected against MPTP by MAO-B inhibitors. Neurotoxicology, <b>29<\/b>, 1141-1146.","DOI":"10.1016\/j.neuro.2008.05.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"He, X.J., Yamauchi, H., Uetsuka, K. and Nakayama, H. (2008b): Neurotoxicity of MPTP to migrating neuroblasts: Studies in acute and subacute mouse models of Parkinson&rsquo;s disease.<b> <\/b>Neuro. Toxicol., <b>29<\/b>, 413-420.","DOI":"10.1016\/j.neuro.2008.02.007"},{"key":"16","unstructured":"Hiebert, C.K., Sayre, L.M. and Silverman, R.B. (1989): Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methy-4-phenyl- 2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation. J. Boil. Chem., <b>264<\/b>, 21516-21215."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ito, T., Suzuki, K., Uchida, K. and Nakayama, H. (2012): 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. Exp. Toxicol. Pathol., <b>64<\/b>, 761-765.","DOI":"10.1016\/j.etp.2011.01.013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ito, T., Uchida, K. and Nakayama, H. (2013a): Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL\/6 and BALB\/c mice. Exp. Toxicol. Pathol., <b>65<\/b>, 121-125.","DOI":"10.1016\/j.etp.2011.06.009"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ito, T., Suzuki, K., Uchida, K. and Nakayama, H. (2013b): Different susceptibility to 1-methyl-4-phenylpiridinium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57Bl\/6 and BALB\/c mice is not related to the difference of monoamine oxidase-B (MAO-B). Exp. Toxicol. Pathol., <b>65<\/b>, 153-158.","DOI":"10.1016\/j.etp.2011.07.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Javitch, J.A. and Snyder, S.H. (1984): Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur. J. Pharmacol., <b>106<\/b>, 455-456.","DOI":"10.1016\/0014-2999(84)90740-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Jenner, P. (2009): From the MPTP-treated primate to the treatment of motor complications in Parkinson&rsquo;s disease. Parkinsonism Relat Disord., <b>15<\/b>, 18-23.","DOI":"10.1016\/S1353-8020(09)70829-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Johannessen, J.N. and Markey, S.P. (1984): Assessment of the opiate properties of two constituents of a toxic illicit drug mixture. Drug Alchol Depend., <b>13<\/b>, 367-374.","DOI":"10.1016\/0376-8716(84)90004-8"},{"key":"23","unstructured":"Johannessen, J.N. and Markey, S.P. (2013): Assessment of the opiate properties of two constituents of a toxic illicit drug mixture. Drug Alcohol Depend., <b>13<\/b>, 367-374."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Johnston, T.H., Fox, S.H., McIldowie, M.J., Piggott, M.J. and Brotchie, J.M. (2010): Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson&rsquo;s Disease. J. Pharmacol. Exp. Ther.,<b> 333<\/b>, 865-873.","DOI":"10.1124\/jpet.110.166629"},{"key":"25","unstructured":"Lam, P.Y., Chen, K. and Shin, J.C. (2004): The circadian rhythm of 5-TH biosynthenic and degradative enzymes in immortalized mouse neuroendcrine pineal cell line-a model for studying circadian thythm. Life Sci., <b>75<\/b>, 3017-3026."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Levitt, P., Pintar, J.E. and Breakefield, X.O. (1982): Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl. Acad. Sci. USA, <b>79<\/b>, 6385-6389.","DOI":"10.1073\/pnas.79.20.6385"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Lotharius, J. and O&rsquo;Malley, K.L. (2000): The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation. A novel mechanism of toxicity. J. Biol. Chem., <b>275<\/b>, 38581-38588.","DOI":"10.1074\/jbc.M005385200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Mandel, S.A., Sagi, Y. and Amit, T. (2007): Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway. Neurochem. Res., <b>32<\/b>, 1694-1699.","DOI":"10.1007\/s11064-007-9351-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Melamed, E., Rosenthal, J. and Youdim, M.B. (1990): Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem., <b>55<\/b>, 1427-1431.","DOI":"10.1111\/j.1471-4159.1990.tb03156.x"},{"key":"30","unstructured":"Mu&ntilde;oz, A., Rey, P., Guerra, M.J., Mendez-Alvarez, E., Soto-Otero, R. and Labandeira-Garcia, J.L. (2006): Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology, <b>51<\/b>, 112-120."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Obata, T. (2006): Nitric oxide and MPP1-induced hydroxyl radical generation. J. Neural. Transm., <b>113<\/b>, 1131-1144.","DOI":"10.1007\/s00702-005-0415-0"},{"key":"32","unstructured":"O&rsquo;Callaghan, J.P. and Seidler, F.J. (1992): 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase. Neurosci. Lett., <b>148<\/b>, 105-108."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Ochi, N., Naoi, M., Mogi, M., Ohya, Y., Mizutani, N., Watanabe, K., Harada, M. and Nagatsu, T. (1991): Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain. Life Sci., <b>48<\/b>, 217-223.","DOI":"10.1016\/0024-3205(91)90348-F"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Ohashi, S., Mori, A., Kurihara, N., Mitsumoto, Y. and Nakai, M. (2006): Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57Bl\/6 mice. Neurosci. Lett., <b>401<\/b>, 183-187.","DOI":"10.1016\/j.neulet.2006.03.017"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Ohya, Y., Naoi, M., Ochi, N., Mizutani, N., Watanabe, K. and Nagatsu, T. (1990): Transplacentally-transported 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects the catecholamine and indoleamine levels in the fetal mouse brain. J. Neural. Transm. Park Dis. Dement. Sect., <b>2<\/b>, 277-283.","DOI":"10.1007\/BF02252922"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Ookubo, M., Yokoyama, H., Kato, H. and Araki, T. (2009): Gender differences on MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL\/6 mice. Mol. Cell. Endocrinol., <b>311<\/b>, 62-68.","DOI":"10.1016\/j.mce.2009.07.011"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Reinhard, J.F.Jr., Diliberto, E.J.Jr., Viveros, O.H., and Daniels, A.J. (1987): Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.<b> <\/b>Proc. Natl. Acad. Sci. USA, <b>84<\/b>, 8160-8164.","DOI":"10.1073\/pnas.84.22.8160"},{"key":"38","unstructured":"Riederer, P., Foley, P., Bringmann, G., Feineis, D., Br&uuml;ckner, R. and Gerlach, M. (2002): Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin? Eur. J. Pharmacol., <b>442<\/b>, 1-16."},{"key":"39","doi-asserted-by":"crossref","unstructured":"Sai, T., Uchida, K. and Nakayama, H. (2013): Acute toxicity of MPTP and MPP<sup>+<\/sup> in the brain of embryo and newborn mice. Exp. Toxicol. Pahol., <b>65<\/b>, 113-119.","DOI":"10.1016\/j.etp.2011.06.008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Seo, B.B., Nakamaru-Ogiso, E., Flotte, T.R., Matsuno-Yagi, A. and Yagi, T. (2006): In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease. J. Biol. Chem., <b>281<\/b>, 14250-14255.","DOI":"10.1074\/jbc.M600922200"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Shibui, Y., He, X.J., Uchida, K. and Nakayama, H. (2009): MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters. Neurotoxicology, <b>30<\/b>, 1036-1044.","DOI":"10.1016\/j.neuro.2009.07.003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Smeyne, M., Jiao, Y., Shepherd, K.R. and Smeyne, R.J. (2005): Glia cell number modulates sensitivity to MPTP in mice. Glia, <b>52<\/b>, 144-152.","DOI":"10.1002\/glia.20233"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Schapira, A.H. (2007): Mitochondrial dysfunction in Parkinson&rsquo;s disease. Cell Death Differ., <b>14<\/b>, 1261-1266.","DOI":"10.1038\/sj.cdd.4402160"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Singer, T.P., Salach, J.I., Castagnoli, N.Jr. and Trevor, A. (1986): Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Biochem. J., <b>235<\/b>, 785-789.","DOI":"10.1042\/bj2350785"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Smith, S.M., Ponnio, T., Conneely, O.M., Burbach, J.P. and Smidt, M.P. (2003): Involvement of Nurrl in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci., <b>18<\/b>, 1731-1738.","DOI":"10.1046\/j.1460-9568.2003.02885.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Sonsalla, P.K., Wong, L.Y., Winnik, B. and Buckley, B. (2010): The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Exp. Neurol., <b>221<\/b>, 329-334.","DOI":"10.1016\/j.expneurol.2009.11.018"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Sugama, S., Yang, L., Cho, B.P., Degiorgio, L.A., Lorenzl, S., Albers, D.S., Beal, M.F., Volpe, B.T. and Joh, T.H. (2003): Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL\/6 mice. Brain Res., <b>964<\/b>, 288-294.","DOI":"10.1016\/S0006-8993(02)04085-4"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Teismann, P., Schwaninger, M., Weih, F. and Ferger, B. (2001): Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson&rsquo;s disease. Neuroreport., <b>12<\/b>, 1049-1053.","DOI":"10.1097\/00001756-200104170-00037"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Vanitallie, T.B. (2008): Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction. Metabolism, <b>57<\/b>, S50-S55.","DOI":"10.1016\/j.metabol.2008.07.015"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Westberry, J.M. and Wilson, M.E. (2012): Regulation of estrogen receptor alpha gene expression in the mouse prefrontal cortex during early postnatal development. Neurogenetics, <b>13<\/b>, 159-167.","DOI":"10.1007\/s10048-012-0323-z"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Wilson, M.E., Westberry, J.M. and Trout, A.L. (2011): Estrogen receptor-alpha gene expression in the cortex: sex differences during development and in adulthood. Horm Behav., <b>59<\/b>, 353-357.","DOI":"10.1016\/j.yhbeh.2010.08.004"},{"key":"52","unstructured":"Wolfgang, S. and Beat, U. (1991): Placental toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Toxicol., <b>67<\/b>, 63-74."},{"key":"53","unstructured":"Xiao, Y.L., Fu, J.M., Dong, Z., Yang, J.Q., Zeng, F.X., Zhu, L.X. and He, B.C. (2004): Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta. Pharmacol. Sin., <b>25<\/b>, 301-305."},{"key":"54","doi-asserted-by":"crossref","unstructured":"Xu, L., Chen, W.F. and Wong, M.S. (2009): Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson&rsquo;s disease through the IGF-1 receptor signaling pathway. Br. J. Pharmacol., <b>158<\/b>, 738-748.","DOI":"10.1111\/j.1476-5381.2009.00361.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Yokoyama, H., Kuroiwa, H., Yano, R. and Araki, T. (2008): Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson&rsquo;s disease. Neurol. Sci., <b>29<\/b>, 293-301.","DOI":"10.1007\/s10072-008-0986-2"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Youngster, S.K., McKeown, K.A., Jin, Y.Z., Ramsay, R.R., Heikkila, R.E. and Singer, T.P. (1989): Oxidatio of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by dopamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products. J. Neurochem., <b>53<\/b>, 1837-1842.","DOI":"10.1111\/j.1471-4159.1989.tb09250.x"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/38\/3\/38_445\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T19:09:38Z","timestamp":1645038578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/38\/3\/38_445\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.38.445","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}